| Year | Title | Author(s) |
| 2024 |
Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastoma
Cancer Medicine |
Seneviratne, JA Ravindrarajah, D Carter, DR Zhai, V Lalwani, A Krishan, S Balachandran, A Ng, E Pandher, R Wong, M Nero, TL Wang, SD Norris, MD Haber, M Liu, T Parker, MW Cheung, BB Marshall, GM |
| 2023 |
Inhibitors of the Oncogenic PA2G4-MYCN Protein-Protein Interface
Cancers |
Massudi, H Luo, JS Holien, JK Gadde, S Krishan, S Herath, M Koach, J Stevenson, BW Gorman, MA Venkat, P Mayoh, C Luo, XQ Parker, MW Cheung, BB Marshall, GM |